The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic

The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic

Background and aim: While the link between antipsychotic treatment and metabolic adverse events, including type 2 diabetes mellitus (T2DM) are clear in adults with schizophrenia, in young this association is not so well studied although the use of secondgeneration antipsychotics (SGA) is more and mo...

Full description

Bibliographic Details
Main Authors: Cason Nicolae-Marius, Babeș Petru Aurel, Béres Enikő, Babeș Katalin
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Romanian Journal of Diabetes Nutrition and Metabolic Diseases
Subjects:
schizophrenia
young adult
second-generation antipsychotic agents
metabolic side effects of drugs and substances
diabetes mellitus type 2
olanzapine
Online Access:https://doi.org/10.2478/rjdnmd-2019-0047

Similar Items

Similar Items